Base to Base Biotech
oleh Jim Cornall
Episode terbaru
Base to Base biotech podcast 83: Different approaches to beating…
Base to Base biotech podcast 83: Different approaches to beating…
Tentang podcast ini
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.
Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.
The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.
Base to Base is an Ayr Coastal Media Ltd production.
Episode
20 episode terbaru dari 83
- Base to Base biotech podcast 83: Different approaches to beating cancer tumours · 48 mnt · Episode 83Times: 03:22 Ona Therapeutics 24:08 Actuate Therapeutics This week, we have a conversation with Valerie Vanhooren, CEO and co-founder of Ona Therapeutics about first-in-class…
- Base to Base biotech podcast 82: Restoring blood flow to the heart and tackling HHT · 53 mnt · Episode 82This week, we have a conversation with Philip Brainin, CEO of Isomab, about restoring blood flow to the heart, and with RougeTx CEO Andrew Lightfoot, about developing a treatment…
- Base to Base biotech podcast 81: Breakthrough in shrinking tumours and restoring mitochondrial metabolism to address obesity · 56 mnt · Episode 81This week, we talk about mitochondria and obesity with Jon Rees, co-founder and CEO of MitoRx Therapeutics, and also have a chat with Apeximmune Therapeutics’ CEO and founder…
- Base to Base biotech podcast 80: Targeting tumour acidity, and developing allosteric therapies · 52 mnt · Episode 80This week, we chat with Ryan Beal, a cancer survivor and founder and CEO of Dyve Biosciences, about tumour acidity, and Gene Mack, president and CEO of Gain Therapeutics, about…
- Base to Base biotech podcast 79: Fragile X syndrome and Parkinson’s disease · 42 mnt · Episode 79This week, we chat with Simon Mølgaard, co-founder and chief executive officer of Teitur Trophics about results from its Parkinson’s disease trial, and have a conversation with…
- Base to Base biotech podcast 78: A new treatment for erectile dysfunction, and nanotechnology for knee osteoarthritis · 43 mnt · Episode 78This week, we chat with Lucas Decuypere, CEO and president of Allegro, about treatment of knee osteoarthritis with a nanotechnology injection, and Elin Trampe, the CEO of Dicot…
- Base to Base biotech podcast 77: Transferring mammal traits to humans, and is injecting tumours a new way to kill cancer? · 54 mnt · Episode 77This week, we chat with Evan Appleton, chief scientific officer and co-founder of Intertwined, a company focused on understanding mammalian evolved protective traits, and how…
- Base to Base biotech podcast 76: Early disease detection and beating CNS cancers · 54 mnt · Episode 76This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous system (CNS) cancers, and Shaun Holt, CEO of Alveo…
- Base to Base biotech podcast 75: AI-powered diagnostics and cancer immunotherapy · 1 jam 2 mnt · Episode 75Times: 03:17 Asgard Therapeutics 32:43 Waiv This week, we talk to a company in Lund, Asgard Therapeutics, and its co-founder and CEO Cristiana Pires, about in vivo direct cell…
- Base to Base biotech podcast 74: A vision for vision, and studying pancreatic cancer · 1 jam 1 mnt · Episode 74This week, our guests are Bryan McClellan, who conducted research on pancreatic cancer as a postdoctoral fellow at Dell Medical School, and William Matsui, the study's senior…
- Base to Base biotech podcast 73: Polymacrocyclic peptides and AI in drug discovery and diagnosis · 51 mnt · Episode 73This week, our guests are chief scientific officer of Valo Health, Karin Conde-Knape, and Karsten Eastman, CEO of Sethera Therapeutics. Times: 03:06 Sethera Therapeutics 20:08…
- Base to Base biotech podcast 72: Cell-free DNA bioproduction · 36 mnt · Episode 72This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction…
- Base to Base biotech podcast 71: The IgA/CD89 axis · 27 mnt · Episode 71This week, we have a conversation Paweł Szczepański, CEO of JJP Biologics about specially-built antibodies to tackle autoimmune diseases and cancer. JJP Biologics JJP Biologics…
- Base to Base biotech podcast 70: Taking the lead on GI motility disorders · 32 mnt · Episode 70This week, we have a conversation with Peter G. Milner, founder and director of Renexxion, about GI motility disorders. Renexxion Renexxion, Inc. is a privately held…
- Base to Base biotech podcast 69: nrHSV-1 technology and environmental testing through hair · 54 mnt · Episode 69Times: 01:33 Cyllene Tx 21:37 LinusBio This week, we have conversations with LinusBio founder and Mt. Sinai environmental professor, Dr. Manish Arora, as well as with Philippe…
- Base to Base biotech podcast 68: Water from air for pharma and beyond · 27 mnt · Episode 68This week, we have a conversation with Kyle Cordova, founder and CEO of AquaPoro. AquaPoro AquaPoro is a deeptech company engineering systems that can harvest water from the…
- Base to Base biotech podcast 67: Synthetic DNA and crossing the blood-brain barrier · 46 mnt · Episode 67Times: 02:58 Deep Science Ventures 22:16 4basebio This week, we have a conversation with Amy Walker, CEO of 4basebio, and Adam Tomassi-Russell, senior director, climate, at Deep…
- Base to Base biotech podcast 66: The future of clinical trials and breakthroughs in molecular testing · 1 jam 0 mnt · Episode 66This week, we have a conversation with Jeff Fischer, president of Longhorn Vaccines & Diagnostics, and with Hannah Amies, founder and CEO of Luvida. Times: 03:03 Longhorn…
- Base to Base biotech podcast 65: Giving medicine a genetic camouflage · 27 mnt · Episode 65This week, we have a conversation with Houdini Bio CEO and co-founder Jonathan Cohen-Gold. Houdini Bio has announced its official launch, having raised approximately £1.5m in…
- Base to Base biotech podcast 64: Solving logistics challenges · 24 mnt · Episode 64This week on Base to Base, we have a conversation with Bora Pharmaceuticals’ chief commercial officer Jean-Baptiste (JB) Agnus. Bora Pharmaceuticals Bora Pharmaceuticals is an…
